Alnylam Pharmaceuticals Inc (ALNY)
152.33
+2.02
(+1.34%)
USD |
NASDAQ |
May 03, 16:00
152.43
+0.10
(+0.07%)
After-Hours: 20:00
Alnylam Pharmaceuticals Free Cash Flow: 127.82M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 127.82M |
| December 31, 2023 | 41.94M |
| September 30, 2023 | -66.56M |
| June 30, 2023 | -540.68M |
| March 31, 2023 | -604.65M |
| December 31, 2022 | -613.33M |
| September 30, 2022 | -631.75M |
| June 30, 2022 | -660.05M |
| March 31, 2022 | -654.28M |
| December 31, 2021 | -718.06M |
| September 30, 2021 | -690.85M |
| June 30, 2021 | -653.50M |
| March 31, 2021 | -672.38M |
| December 31, 2020 | -685.32M |
| September 30, 2020 | -775.30M |
| June 30, 2020 | -871.24M |
| March 31, 2020 | -451.80M |
| December 31, 2019 | -418.58M |
| September 30, 2019 | -371.77M |
| June 30, 2019 | -352.30M |
| March 31, 2019 | -745.14M |
| December 31, 2018 | -689.50M |
| September 30, 2018 | -625.30M |
| June 30, 2018 | -550.13M |
| March 31, 2018 | -527.43M |
| Date | Value |
|---|---|
| December 31, 2017 | -487.00M |
| September 30, 2017 | -461.44M |
| June 30, 2017 | -433.23M |
| March 31, 2017 | -413.30M |
| December 31, 2016 | -372.26M |
| September 30, 2016 | -330.20M |
| June 30, 2016 | -295.21M |
| March 31, 2016 | -269.16M |
| December 31, 2015 | -202.09M |
| September 30, 2015 | -186.09M |
| June 30, 2015 | -169.15M |
| March 31, 2015 | -160.90M |
| December 31, 2014 | -174.60M |
| September 30, 2014 | -157.69M |
| June 30, 2014 | -136.45M |
| March 31, 2014 | -111.96M |
| December 31, 2013 | -72.66M |
| September 30, 2013 | -119.01M |
| June 30, 2013 | -96.87M |
| March 31, 2013 | -96.25M |
| December 31, 2012 | -123.96M |
| September 30, 2012 | -80.04M |
| June 30, 2012 | -108.82M |
| March 31, 2012 | -112.50M |
| December 31, 2011 | -88.36M |
Free Cash Flow Range, Past 5 Years
-871.24M
Minimum
Jun 2020
127.82M
Maximum
Mar 2024
-513.13M
Average
-622.54M
Median
Free Cash Flow Benchmarks
| Ionis Pharmaceuticals Inc | -335.52M |
| Pfizer Inc | 4.793B |
| Blueprint Medicines Corp | -452.91M |
| BridgeBio Pharma Inc | -605.72M |
| Madrigal Pharmaceuticals Inc | -325.71M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -81.52M |
| Cash from Investing (Quarterly) | -67.62M |
| Cash from Financing (Quarterly) | 28.91M |
| Free Cash Flow Per Share (Quarterly) | -0.7491 |
| Free Cash Flow to Equity (Quarterly) | -95.44M |
| Free Cash Flow to Firm (Quarterly) | -88.67M |
| Free Cash Flow Yield | 0.66% |